
Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

